Meta-Analysis of Grazoprevir plus Elbasvir for Treatment of Hepatitis C Virus Genotype 1 Infection

Meta-Analysis of Grazoprevir plus Elbasvir for Treatment of Hepatitis C Virus Genotype 1 Infection

Background and aim. Grazoprevir is an NS3/4A protease inhibitor (PI), while elbasvir is an NS5A inhibitor. We performed this meta-analysis to directly compare grazoprevir plus elbasvir and ribavirin regimen vs. grazoprevir and elbasvir without ribavirin in the treatment of hepatitis C virus genotype...

Full description

Bibliographic Details
Main Authors: Hussien Ahmed, Abdelrahman Ibrahim Abushouk, Amr Menshawy, Attia Attia, Arwa Mohamed, Ahmed Negida, Mohamed M. Abdel-Daim
Format: Article
Language:English
Published: Elsevier 2018-01-01
Series:Annals of Hepatology
Subjects:
Grazoprevir
Elbasvir
Ribavirin
Hepatitis C virus
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119301048

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119301048

Similar Items